Hyperviscosity Syndrome in Undifferentiated Connective Tissue Disease: A Diagnostic and Therapeutic Challenge
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
Hyperviscosity is an uncommon manifestation of various underlying diseases. Rapid diagnosis and management of the underlying disease is crucial to prevent significant complications, including hypertension, cerebral vascular accidents, pulmonary embolism, bowel ischemia, and ophthalmologic pathologies. Although the acute management of complications arising from hyperviscosity is relatively straightforward, identifying and treating the underlying cause can prove difficult. This case highlights the difficulties of establishing a diagnosis and initiating appropriate management for a patient with hyperviscosity syndrome in a suspected rheumatologic disorder.
References
1.
Opinc A, Makowska J
. Antisynthetase syndrome - much more than just a myopathy. Semin Arthritis Rheum. 2020; 51(1):72-83.
DOI: 10.1016/j.semarthrit.2020.09.020.
View
2.
Rubio J, Kyttaris V
. Undifferentiated Connective Tissue Disease: Comprehensive Review. Curr Rheumatol Rep. 2023; 25(5):98-106.
DOI: 10.1007/s11926-023-01099-5.
View
3.
Linker C
. Plasmapheresis in clinical medicine. West J Med. 1983; 138(1):60-9.
PMC: 1010632.
View
4.
Okafor C, Ward D, Mokrzycki M, Weinstein R, Clark P, Balogun R
. Introduction and overview of therapeutic apheresis. J Clin Apher. 2010; 25(5):240-9.
DOI: 10.1002/jca.20247.
View
5.
Pipitone N, Salvarani C
. Up-to-date treatment and management of myositis. Curr Opin Rheumatol. 2020; 32(6):523-527.
DOI: 10.1097/BOR.0000000000000745.
View